Diptee Kulkarni
Impact in
-
- Cancer-related Molecular Pathways
-
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
Papers in
-
- Protein Degradation and Inhibitors 2
- Melanoma and MAPK Pathways 2
- Ubiquitin and proteasome pathways 2
- Cancer therapeutics and mechanisms 1
- Oncology 8
- Cancer-related Molecular Pathways 4
- Co-authors
- Kim M. Hirshfield (5 shared papers)Ahamed Saleem (3 shared papers)Eric H. Rubin (3 shared papers)Pooja Pungaliya (3 shared papers)Deborah Toppmeyer (3 shared papers)Arnold J. Levine (3 shared papers)Alexei Vázquez (3 shared papers)Hyejin Park (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)International Journal of Cancer (2 papers)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Diptee Kulkarni
13 papers receiving 301 citations
Peers
Comparison fields: 5 of 57
- Oncology 103
- Hepatology 27
- Molecular Biology 192
- Cancer Research 41
- Pathology and Forensic Medicine 29
Countries citing papers authored by Diptee Kulkarni
This map shows the geographic impact of Diptee Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diptee Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diptee Kulkarni more than expected).
Fields of papers citing papers by Diptee Kulkarni
This network shows the impact of papers produced by Diptee Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diptee Kulkarni. The network helps show where Diptee Kulkarni may publish in the future.
Co-authors
The 25 scholars most cited alongside Diptee Kulkarni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 58 | |
| 2 | 2007 | 49 | |
| 3 | 2022 | 42 | |
| 4 | 2010 | 37 | |
| 5 | 2009 | 29 | |
| 6 | 2010 | 25 | |
| 7 | 2007 | 18 | |
| 8 | 2010 | 17 | |
| 9 | 2010 | 11 | |
| 10 | 2008 | 9 | |
| 11 | 2016 | 7 | |
| 12 | 2014 | 1 | |
| 13 | 2009 | 1 |
About Diptee Kulkarni
Diptee Kulkarni is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Organic Chemistry, having authored 13 papers that have together received 304 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Protein Degradation and Inhibitors (2 papers), Melanoma and MAPK Pathways (2 papers), Cancer Genomics and Diagnostics (2 papers), Ubiquitin and proteasome pathways (2 papers), Phagocytosis and Immune Regulation (1 paper), Computational Drug Discovery Methods (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (103 citations), Hepatology (27 citations), Molecular Biology (192 citations), Cancer Research (41 citations) and Pathology and Forensic Medicine (29 citations). Diptee Kulkarni has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Kim M. Hirshfield, Ahamed Saleem, Eric H. Rubin, Pooja Pungaliya, Deborah Toppmeyer, Arnold J. Levine, Alexei Vázquez, Hyejin Park, Haiyan Zheng and Henry Lackland. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Cancer, Clinical Cancer Research, Investigational New Drugs and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.